NeuBase Therapeutics, Inc.

NBSE · NASDAQ
Analyze with AI
9/30/2022
9/30/2021
9/30/2020
9/30/2019
Assets
Cash & Equivalents$23,153$52,893$31,992$10,314
Short-Term Investments$0$0$0$0
Receivables$128$0$0$0
Inventory-$128$0$0$0
Other Curr. Assets$1,496$2,035$295$266
Total Curr. Assets$24,649$54,929$32,809$11,029
Property Plant & Equip (Net)$7,772$8,409$1,167$431
Goodwill$0$0$0$0
Intangibles$0$0$0$146
Long-Term Investments$0$416$324$586
Tax Assets$0$0$0$0
Other NC Assets$273$414$145$339
Total NC Assets$8,045$9,239$1,636$1,502
Other Assets$0$0$0$0
Total Assets$32,693$64,168$34,444$12,531
Liabilities
Payables$1,843$1,808$1,505$1,477
Short-Term Debt$661$639$139$123
Tax Payable$37$31$156$0
Deferred Revenue$0$0$556$406
Other Curr. Liab.$1,626$1,717$794$496
Total Curr. Liab.$4,166$4,194$3,150$2,502
LT Debt$5,335$5,904$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0-$0$0$0
Total NC Liab.$5,335$5,904$1,645$0
Other Liabilities$0$0-$1,645$0
Cap. Leases$0$0$0$0
Total Liabilities$9,502$10,098$3,150$2,502
Equity
Pref Stock$0$0$0$0
Common Stock$3$3$2$2
Retained Earnings-$102,744-$68,968-$43,559-$27,000
AOCI$0$0-$0$0
Other Equity$125,933$123,034$74,851$37,028
Total Equity$23,192$54,070$31,295$10,029
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$32,693$64,168$34,444$12,531
Net Debt-$17,157-$46,351-$31,854-$10,191